BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 18270260)

  • 1. A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors.
    Berna MJ; Annibale B; Marignani M; Luong TV; Corleto V; Pace A; Ito T; Liewehr D; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
    J Clin Endocrinol Metab; 2008 May; 93(5):1582-91. PubMed ID: 18270260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric enterochromaffin-like cell changes in multiple endocrine neoplasia type 1.
    Manoharan J; Anlauf M; Albers MB; Denzer UW; Mintziras I; Wächter S; Di Fazio P; Bollmann C; Bartsch DK
    Clin Endocrinol (Oxf); 2021 Sep; 95(3):439-446. PubMed ID: 33506527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas.
    Richards ML; Gauger P; Thompson NW; Giordano TJ
    World J Surg; 2004 Jul; 28(7):652-8. PubMed ID: 15383867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical aspects of ECL-cell abnormalities.
    Hirschowitz BI
    Yale J Biol Med; 1998; 71(3-4):303-10. PubMed ID: 10461361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome.
    Feurle GE
    Gut; 1994 Feb; 35(2):275-7. PubMed ID: 8307483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas.
    Peghini PL; Annibale B; Azzoni C; Milione M; Corleto VD; Gibril F; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
    Gastroenterology; 2002 Jul; 123(1):68-85. PubMed ID: 12105835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids.
    Debelenko LV; Emmert-Buck MR; Zhuang Z; Epshteyn E; Moskaluk CA; Jensen RT; Liotta LA; Lubensky IA
    Gastroenterology; 1997 Sep; 113(3):773-81. PubMed ID: 9287968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypergastrinemia and gastric enterochromaffin-like cells.
    Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
    Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antral mucosa as a new site for endocrine tumors in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndromes.
    Bordi C; Corleto VD; Azzoni C; Pizzi S; Ferraro G; Gibril F; Delle Fave G; Jensen RT
    J Clin Endocrinol Metab; 2001 May; 86(5):2236-42. PubMed ID: 11344233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric endocrine cell proliferation and fundic argyrophil carcinoid tumors in patients with the Zollinger-Ellison syndrome.
    Cadiot G; Lehy T; Mignon M
    Acta Oncol; 1993; 32(2):135-40. PubMed ID: 8323754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis.
    Solcia E; Rindi G; Silini E; Villani L
    Baillieres Clin Gastroenterol; 1993 Mar; 7(1):149-65. PubMed ID: 7682874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids.
    Azzoni C; Doglioni C; Viale G; Delle Fave G; De Boni M; Caruana P; Ferraro G; Bordi C
    Am J Surg Pathol; 1996 Apr; 20(4):433-41. PubMed ID: 8604810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypergastrinemia and enterochromaffin-like cell hyperplasia.
    Delle Fave G; Marignani M; Moretti A; D'Ambra G; Martino G; Annibale B
    Yale J Biol Med; 1998; 71(3-4):291-301. PubMed ID: 10461360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric carcinoids in patients with hypergastrinemia.
    Jordan PH; Barroso A; Sweeney J
    J Am Coll Surg; 2004 Oct; 199(4):552-5. PubMed ID: 15454137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of ECL cell tumors in humans.
    Bordi C; D'Adda T; Azzoni C; Ferraro G
    Yale J Biol Med; 1998; 71(3-4):273-84. PubMed ID: 10461358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with multiple endocrine neoplasia type 1 with gastrinomas have an increased risk of severe esophageal disease including stricture and the premalignant condition, Barrett's esophagus.
    Hoffmann KM; Gibril F; Entsuah LK; Serrano J; Jensen RT
    J Clin Endocrinol Metab; 2006 Jan; 91(1):204-12. PubMed ID: 16249283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fundic argyrophil carcinoid tumor in a patient with sporadic-type Zollinger-Ellison syndrome.
    Cadiot G; Vissuzaine C; Potet F; Mignon M
    Dig Dis Sci; 1995 Jun; 40(6):1275-8. PubMed ID: 7781446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.
    Gilligan CJ; Lawton GP; Tang LH; West AB; Modlin IM
    Am J Gastroenterol; 1995 Mar; 90(3):338-52. PubMed ID: 7872269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of vesicular monoamine transporters in endocrine hyperplasia and endocrine tumors of the oxyntic stomach.
    Eissele R; Anlauf M; Schäfer MK; Eiden LE; Arnold R; Weihe E
    Digestion; 1999; 60(5):428-39. PubMed ID: 10473967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature.
    Gibril F; Schumann M; Pace A; Jensen RT
    Medicine (Baltimore); 2004 Jan; 83(1):43-83. PubMed ID: 14747767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.